Iijima S

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Clinical and pathophysiologic relevance of autoantibodies in neonatal myasthenia gravis - Iijima_2021_Pediatr.Neonatol__
Author(s) : Iijima S
Ref : Pediatr Neonatol , : , 2021
Abstract : Iijima_2021_Pediatr.Neonatol__
ESTHER : Iijima_2021_Pediatr.Neonatol__
PubMedSearch : Iijima_2021_Pediatr.Neonatol__
PubMedID: 34272198

Title : Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis - Ingram_1994_Life.Sci_55_2037
Author(s) : Ingram DK , Spangler EL , Iijima S , Ikari H , Kuo H , Greig NH , London ED
Ref : Life Sciences , 55 :2037 , 1994
Abstract : Ingram_1994_Life.Sci_55_2037
ESTHER : Ingram_1994_Life.Sci_55_2037
PubMedSearch : Ingram_1994_Life.Sci_55_2037
PubMedID: 7997063

Title : Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze - Iijima_1993_Psychopharmacology_112_415
Author(s) : Iijima S , Greig NH , Garofalo P , Spangler EL , Heller B , Brossi A , Ingram DK
Ref : Psychopharmacology , 112 :415 , 1993
Abstract : Iijima_1993_Psychopharmacology_112_415
ESTHER : Iijima_1993_Psychopharmacology_112_415
PubMedSearch : Iijima_1993_Psychopharmacology_112_415
PubMedID: 7871051

Title : The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14- unit T-maze - Iijima_1992_Neurosci.Lett_144_79
Author(s) : Iijima S , Greig NH , Garofalo P , Spangler EL , Heller B , Brossi A , Ingram DK
Ref : Neuroscience Letters , 144 :79 , 1992
Abstract : Iijima_1992_Neurosci.Lett_144_79
ESTHER : Iijima_1992_Neurosci.Lett_144_79
PubMedSearch : Iijima_1992_Neurosci.Lett_144_79
PubMedID: 1436716